Form 4: Edgewise Therapeutics Executive Sells Shares to Cover Tax Obligations

John R. Moore, General Counsel of Edgewise Therapeutics, sold shares to cover statutory tax withholding obligations related to vesting Restricted Stock Units.

Summary

• On May 1, 2025, John R. Moore, General Counsel of Edgewise Therapeutics, exercised Restricted Stock Units (RSUs) and sold 5,209 shares to cover statutory tax withholding obligations.
• On May 2, 2025, Moore sold 1,930 shares of common stock at an average price of $16.4542 per share.
• Following these transactions, Moore beneficially owns 6,531 shares of Edgewise Therapeutics.
• The sale on May 1, 2025 was to cover tax obligations related to the vesting of RSUs and was not a discretionary sale.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction (sell-to-cover) and doesn't inherently indicate positive or negative sentiment. It's a neutral event in the context of executive compensation and tax obligations.

Management Comments

• The sale satisfies the minimum statutory tax withholding obligations to be funded by a 'sell-to-cover' transaction and does not represent a discretionary sale by the Reporting Person.

Industry Context

Executive stock sales are a common occurrence, often related to compensation and tax obligations. Monitoring these transactions can provide insights into management's perspective on the company's value.

Stakeholder Impact

• The sale of shares could have a minor impact on shareholders due to the increased supply of shares in the market, but it is unlikely to be significant given the purpose of the sale.

Key Dates

Keywords

EWTX, Edgewise Therapeutics, Form 4, John R. Moore, Stock Sale, Restricted Stock Units, Tax Withholding, General Counsel, Beneficial Ownership